True stories from scientists and patients around the globe
Over the past decade, several strains (types) of Salmonella typhi have become resistant to multiple antibiotics. Resistant strains have been identified across the globe. However, the 2018 launch of a vaccine has slowed infections. It is estimated that TCV introduction with a catch-up campaign will avert 42.5 million cases and 506,000 deaths caused by fluoroquinolone-resistant typhoid fever, and 21.2 million cases and 342,000 deaths from multidrug-resistant typhoid fever over 10 years following introduction. This episode will cover the impact of vaccinations and the challenges to deploy effective programs.
Guests:
For more information on the impact of typhoid conjugate vaccines and AMR, check out CIDRAP-ASP's report, A Vaccine Is a Bridge: The New Era of Typhoid Prevention.
In this episode, we discuss sepsis and the challenge of an infection caused by a drug-resistant microorganism. Our guests describe the long-term patient experience of surviving and living with a sepsis diagnosis, as well as the current diagnosis and treatment options for sepsis. Finally, we discuss global approaches for new treatments, and the need for advocacy and awareness.
In this episode we discuss the global impact of multidrug-resistant gram-negative bacterial infections. Our guests in this episode will describe the experience of living through, diagnosing, and managing these difficult-to-treat infections.
